PREDICTING OLIGURIA FOLLOWING INDOMETHACIN FOR TREATMENT OF PATENT DUCTUS-ARTERIOSUS

被引：10

作者：

BARRINGTON, KJ

FOX, M

机构：

[1] Division of Newborn Medicine, Department of Pediatrics, University of Alberta, Edmonton, Alberta

来源：

AMERICAN JOURNAL OF PERINATOLOGY | 1994年 / 11卷 / 03期

关键词：

D O I：

10.1055/s-2008-1040750

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Fifty-two consecutive infants who received intravenous indomethacin, 0.2 mg/kg, were reviewed to determine factors associated with the occurrence of oliguria. Serum creatinine and concentration prior to indomethacin did not predict the occurrence of oliguria. A mean urine output of less than 4.5 mL/kg/hr prior to the administration of indomethacin was the only factor that we determined to be associated with a significant risk of oliguria. Two infants developed symptomatic oliguria and both had a preindomethacin urine output less than 1.5mL/kg/hr.

引用

页码：220 / 222

页数：3

共 13 条

[1]

Walters M., Tolerance of intravenous indomethacin treat tnent for premature infants with patent ductus arterio sus, Br Med J, 297, (1988)

[2]

Cifuentes R.F., Olley P.M., Balfe J.W., Et al., Indomethacin andrenal function in premature infants with persistent patent ductus arteriosus, J Pediatr, 95, (1979)

[3]

Catterton Z., Sellers B., Gray B., Insulin clearance in thepremature infant receiving indomethacin, J Pediatr, 96, (1980)

[4]

Wennberg R.P., Goetzman B.W., Neonatal intensive care manual, (1985)

[5]

Polin R.A., Burg F.D., Workbook in practical neonatology, (1983)

[6]

Powlak R.P., Herfert I.A.T., Drug administration in the NICU:a handbook for nurses, (1990)

[7]

Gersony W.M., Peckham G.J., Ellison R.C., Et al., Effects ofindomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study, J Pediatr, 102, pp. 895-906, (1983)

[8]

Fox M.D., Measurement of urine output volume: accuracy ofdiaper weights in neonatal environments, Neonatal Network, 11, pp. 11-18, (1992)

[9]

Karig W., Brown J., Schonfeld J., Et al., Effects ol tenoxican &indomethacin on the release of histamine, prostaglandin E2 and leukotrienes from various cells, Arzaeim-Forsch, 37, (1987)

[10]

Dochertey J.C., W#x0027

← 1 2 →